Navigation Links
Nutrition 21 Announces Fiscal First Quarter 2010 Financial Results
Date:11/4/2009

09 2009 ---- ---- (unaudited) (Note 1) ASSETS Current assets: Cash and cash equivalents $592 $1,373 Accounts receivable, net 2,357 2,752 Other receivables, net 90 516 Inventories, net 3,582 3,878 Other current assets 264 467 Property and equipment, net 44 46 Patents, trademarks and other intangibles, net 750 766 Goodwill and other intangibles with indefinite lives 3,636 3,636 Other assets 1,116 1,389 ----- ----- TOTAL ASSETS $12,431 $14,823 ======= ======= LIABILITIES AND STOCKHOLDERS' DEFICIT Short-term borrowings $3,070 $4,457 Accounts payable 4,068 4,439 Accrued expenses 1,540 2,218 Deferred income 144 361 Deferred income taxes 1,200 1,200 8% Series J convertible preferred stock subject to mandatory redemption 13,658 13,218 ------ ------ Total liabilities 23,680 25,893 ------ ------ Stockholders' Deficit (11,249) (11,070)
'/>"/>
SOURCE Nutrition 21, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. IOM recommends new nutritional requirements for school meal programs
2. Fitness Nutritions Amino Acid Complex Olympic Champion Dara Torres Calls The Best Product Ive Ever Used, Selects TransMedia for PR
3. For Older Adults, Good Nutrition and Exercise Are Key To Staying Healthy & Active
4. Nutrition Still Not A Grade in U.S. Schools: Studies
5. Bariatric Advantage Re- Launches ProMend ABG Designed to Nutritionallly Support Pre and Post Plastic Reconstructive Surgery Patient
6. Compatible Technology International Project to Enhance Child Nutrition and Livelihoods of Rural Families in Malawi and Tanzania
7. Protica Teams With UNFI/Select Nutrition to distribute All-Natural Protein Shot, Proasis
8. Innovative New Book Series Encourages Kids to Go Behind Their Parents' Backs and Listen to Experts on Important Health and Wellness, Education, Personal Finance and Nutrition
9. Senior Living Residences Launches Innovative Nutrition Program to Promote Cognitive Health and Lower the Risk of Alzheimers Disease
10. Frost & Sullivan Cites Arm & Hammer for Excellence in the Dairy Animal Nutrition and Management Market
11. People with type 2 diabetes not meeting important nutritional recommendations
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:RecoverCare Announces the Relocation of Corporate Headquarters to Louisville 2RecoverCare Announces the Relocation of Corporate Headquarters to Louisville 3Ameritox(R) Appoints Jay B. Zimmerman as Chief Operating Officer 2Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 2Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 3Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 4Michael S Burg Appointed as Co Lead Counsel in the Yasmin Yaz Multidistrict Litigation 61325 1Michael S Burg Appointed as Co Lead Counsel in the Yasmin Yaz Multidistrict Litigation 61325 2Esperion Therapeutics Initiates Phase I Clinical Study for ETC 1002 14833 1Esperion Therapeutics Initiates Phase I Clinical Study for ETC 1002 14833 2ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 1ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 2ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 3ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 4ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 5ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 6ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 7ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 8ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 9ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 10ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 11